Assignee
HUA MEDICINE SHANGHAI LTD
CN·13 granted patents·5 pending applications·17 citations·filing 2016–2024
Top patents by PatentIndex Score
18 records- 0189US11266630B2Oral preparation of glucokinase activator and preparation method thereforHUA MEDICINE SHANGHAI LTD·Filed 2017·Granted Mar 8, 2022·12 cites·34 claims
- 0284US12054477B2Prodrug of pyrrolidone derivatives as glucokinase activatorHUA MEDICINE SHANGHAI LTD·Filed 2023·Granted Aug 6, 2024·1 cites·19 claims
- 0384US2024299357A1Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and dpp-iv inhibitor, and preparation method and use thereofHUA MEDICINE SHANGHAI LTD·Filed 2024·Application pending·0 cites
- 0483US11813274B2Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitorHUA MEDICINE SHANGHAI LTD·Filed 2021·Granted Nov 14, 2023·1 cites·29 claims
- 0583US11666556B2Pharmaceutical combination, composition and compound preparation containing glucokinase activator and K-ATP channel blocker, preparation method therefor and use thereofHUA MEDICINE SHANGHAI LTD·Filed 2019·Granted Jun 6, 2023·1 cites·23 claims
- 0682US11872221B2Treating untreated or treatment-resistant diabetes with glucokinase activatorHUA MEDICINE SHANGHAI LTD·Filed 2021·Granted Jan 16, 2024·1 cites·29 claims
- 0781US2023346748A1Pharmaceutical combination, composition and compound preparation containing glucokinase activator and k-atp channel blocker, preparation method therefor and use thereofHUA MEDICINE SHANGHAI LTD·Filed 2023·Application pending·0 cites
- 0879US11857536B2Glucokinase activator for treating diabetes with renal impairmentHUA MEDICINE SHANGHAI LTD·Filed 2021·Granted Jan 2, 2024·1 cites·45 claims
- 0973US12318366B2Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereofHUA MEDICINE SHANGHAI LTD·Filed 2019·Granted Jun 3, 2025·0 cites·39 claims
- 1073US12064416B2Pharmaceutical combination containing glucose kinase activator and PPAR receptor activator, composition, compound preparation method for same, and uses thereofHUA MEDICINE SHANGHAI LTD·Filed 2019·Granted Aug 20, 2024·0 cites·43 claims
- 1172US11992477B2Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereofHUA MEDICINE SHANGHAI LTD·Filed 2019·Granted May 28, 2024·0 cites·63 claims
- 1272US11963947B2Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereofHUA MEDICINE SHANGHAI LTD·Filed 2019·Granted Apr 23, 2024·0 cites·28 claims
- 1368US2024336597A1Prodrug of pyrrolidone derivatives as glucokinase activatorHUA MEDICINE SHANGHAI LTD·Filed 2024·Application pending·0 cites
- 1464US2022202779A1Oral preparation of glucokinase activator and preparation method thereforHUA MEDICINE SHANGHAI LTD·Filed 2022·Application pending·0 cites
- 1547US2023270723A1Glucokinase activator for treating diabetes with hepatic impairmentHUA MEDICINE SHANGHAI LTD·Filed 2021·Application pending·0 cites
- 1639US10328054B2Substituted pyrrolidines as mGluR5 antagonistsHUA MEDICINE SHANGHAI LTD·Filed 2016·Granted Jun 25, 2019·0 cites·24 claims
- 1738US10941132B2Pyrazole derivativesHUA MEDICINE SHANGHAI LTD·Filed 2016·Granted Mar 9, 2021·0 cites·14 claims
- 1837US10669255B2Pyrrole derivativesHUA MEDICINE SHANGHAI LTD·Filed 2016·Granted Jun 2, 2020·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when HUA MEDICINE SHANGHAI LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →